All-Trans Retinoic Acid Boosts Lung Cancer Chemotherapy

Adding all-trans retinoic acid (ATRA) to cisplatin and paclitaxel improves outcome in patients with advanced non-small-cell lung cancer, Mexican researchers report in a June 14th online paper in the Journal of Clinical Oncology.